Beike Biotechnology Receives International Recognition for Quality Control Processes

Leading Chinese Stem Cell Therapy Provider Awarded Three ISO9001 Certifications for Stem Cell Technology Quality Management System TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the…

Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials

TAIZHOU, Jiangsu, China, January 6 – The Jiangsu Government’s Science and Technology Department has announced a $1.8 million grant – the Jiangsu Technological Achievements Transformational Grant – to support the…

Beike CSO Speaks at IPA Diabetic Foot Care Conference, India

NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ — Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic…

China Breaks Ground on Stem Cell Storage & Processing Facility

Taizhou, Jiangsu, China, 7 April 2009 – Jiangsu government’s China Medical City (CMC) and Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com) broke ground on the 20,000 square-meter Stem Cell Regenerative Medicine…

Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell

Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established…

Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.

SHENZHEN, China, Nov. 4 /PRNewswire-Asia/ — Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ), China’s leading stem cell research and regenerative medicine company, announced that it has entered into an agreement…


1 2 7 8 9